Lakeway, TX -- (SBWIRE) -- 02/21/2013 -- vb-news.net, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
AbbVie Inc (NYSE:ABBV) shares gained 1.10% to $38.61. The board of directors of AbbVie, on Feb. 15, declared a quarterly cash dividend and also authorized a share repurchase program of up to $1.5 billion of the Company’s outstanding common stock. The cash dividend of $0.40 per share is payable May 15, 2013 to stockholders of record at the close of business on April 15, 2013.
Additionally, the company will present at the Cowen and Company 33(rd) Annual Health Care Conference on Wednesday, March 6, 2013. Bill Chase, executive vice president and chief financial officer, will make a formal presentation on the company at 7:40 a.m. Central time.
How Should Investors Trade ABBV After The Solid Jump? Let’s Find Out Here
Hot Topic, Inc. (NASDAQ:HOTT) shares jumped 1.07% and closed at $11.35 in the last trading session. The company, on Feb. 6, said that its same-store sales rose 2.6% in the fourth quarter, while net sales for the quarter increased 11% to $233.0 million. For the fourth quarter, same-store sales grew 2% at the company's namesake stores and 5.4% at Torrid stores. The company said it now expects fourth quarter earnings of $0.26 to $0.27 per share, compared to its prior guidance of $0.23 to $0.27 per share. Analysts currently expect the company to earn $0.25 per share on revenue of $229.13 million for the fourth quarter.
click my link Is HOTT Ready To Jump Again After The Solid Momentum? Get Free Trend Analysis Here
TASER International, Inc. (NASDAQ:TASR) shares jumped 1.06% and closed at $8.59 in the last trading session. The company announced that the fourth quarter 2012 earnings call is scheduled for Thursday, February 21, 2013. A conference call is scheduled at 10 a.m. ET to review fourth quarter financial results.
Is TASR Buy After The Recent Price Movement? Find Out Here
Merck & Co., Inc.(NYSE:MRK) shares gained 1.04% to $42.66 after MRK‘s stock had its “overweight” rating restated by equities researchers at JPMorgan Chase in a report issued on Feb. 19. They currently have a $52.00 target price on the stock.
Additionally, the company last week said it will pay $688 million to settle two federal securities class-action lawsuits brought by investors who bought certain Merck and Schering-Plough Corp. securities and claimed they lost money when the results of a trial were published in 2008.
Is MRK a Buy At The Current Market Price? Don’t Miss Out Our Special Coverage Here
vb-news.net’s team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.
The assembled information disseminated by vb-news.net is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. vb-news.net does expect that investors will buy and sell securities based on information assembled and presented in vb-news.net. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)